GlassScriptPhysician profile
Roman S Prager
NPI 1568789634
$1,882.27
in general payments reported to CMS, 2019-2025
11 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Clinical & Laboratory Immunology (Internal Medicine) provider received nationally (typical 2025 total: $523).
See the full distribution for Clinical & Laboratory Immunology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $142 · 2021: $426 · 2022: $180 · 2023: $28.75 · 2024: $234 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $462.32 | 2019-2022 | |
| Boston Scientific Corporation | $400.52 | 2021-2024 | Watchman Flx |
| Medtronic, INC. | $316.53 | 2021-2025 | Selectsecure |
| Biotissue Holdings INC. | $231.32 | 2024-2025 | |
| Medtronic Vascular, INC. | $141.59 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $124.34 | 2019 | |
| Novartis Pharmaceuticals Corporation | $121.48 | 2019 | |
| Novo Nordisk INC | $29.49 | 2021-2023 | Rybelsus, Ozempic |
| Si-Bone, INC. | $25.95 | 2025 | |
| Medtronic Minimed, INC. | $15.13 | 2019 | |
| Acarix USA INC. | $13.60 | 2023 | Cadscor System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roman Prager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.